Carcinoma Ex Pleomorphic Adenoma of the Salivary Gland: an Immunohistochemical Study

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2007 Feb 21

PMID 17310348

Citations 6

Authors

Saori Matsubayashi

Toshio Yoshihara

Affiliations

Soon will be listed here.

Abstract

The proliferative activity of the tumor cells and the expression of tumor-associated genes and sex steroid hormone receptors were investigated immunohistochemically in ten cases of carcinoma ex pleomorphic adenoma (Ca-ex-PA) of the salivary glands. These were analyzed in benign and malignant components separately, and then were compared with ten cases of the other malignant tumors [adenocarcinomas, not otherwise specified (ACN) and salivary duct carcinomas (SDC)] and ten cases of pleomorphic adenomas (PA). The results obtained in this study were as follows: (1) malignant component of Ca-ex-PA showed a higher incidence of PCNA and Ki67 than benign component of Ca-ex-PA. A significant difference between benign component of Ca-ex-PA and PA was not observed. (2) A significant difference in the incidence of p53, c-erbB-2, EGFR overexpression was observed only between malignant component of Ca-ex-PA and benign component of Ca-ex-PA. (3) The incidence of PCNA, Ki67, p53, c-erbB-2 overexpression in malignant component of Ca-ex-PA showed the highest data among the four groups. These results suggest that Ca-ex-PA acquired the particular biological behavior in contrast to the other salivary neoplasms in the long-standing process while PA undergoes malignant transformation.

Citing Articles

Immunohistochemical analysis of proliferating cell nuclear antigen and minichromosome maintenance complex component 7 in benign and malignant salivary gland tumors.

Shamloo N, Taghavi N, Ahmadi S, Shalpoush S Dent Res J (Isfahan). 2022; 19:17.

PMID: 35308440 PMC: 8927963. DOI: 10.4103/1735-3327.338780.

Increase in Chymase-Positive Mast Cells in Recurrent Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland.

Kinoshita I, Jin D, Higashino M, Terada T, Kurisu Y, Takai S Int J Mol Sci. 2021; 22(23).

PMID: 34884420 PMC: 8657626. DOI: 10.3390/ijms222312613.

Carcinoma ex pleomorphic adenoma of the palate composed of invasive micropapillary salivary duct carcinoma and adenoid cystic carcinoma components: an unusual case with immunohistochemical approach.

Sedassari B, da Silva Lascane N, Tobouti P, Pigatti F, Franco M, de Sousa S Medicine (Baltimore). 2014; 93(27):e146.

PMID: 25501054 PMC: 4602770. DOI: 10.1097/MD.0000000000000146.

Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses.

Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T Head Neck. 2013; 36(3):E28-35.

PMID: 24038506 PMC: 4296234. DOI: 10.1002/hed.23466.

Canine mammary mixed tumours: a review.

Cassali G, Bertagnolli A, Ferreira E, Damasceno K, Gamba C, de Campos C Vet Med Int. 2012; 2012:274608.

PMID: 23193497 PMC: 3485544. DOI: 10.1155/2012/274608.

References

Karja V, Syrjanen K, Kurvinen A, Syrjanen S . Expression and mutations of p53 in salivary gland tumours. J Oral Pathol Med. 1997; 26(5):217-23. DOI: 10.1111/j.1600-0714.1997.tb01227.x. View

Nasser S, Faquin W, Dayal Y . Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003; 119(6):801-6. DOI: 10.1309/RVTP-1G0Q-727W-JUQD. View

Yamada K, Iwai K, Okada Y, Mori M . Immunohistochemical expression of epidermal growth factor receptor in salivary gland tumours. Virchows Arch A Pathol Anat Histopathol. 1989; 415(6):523-31. DOI: 10.1007/BF00718645. View

Jeannon J, Soames J, Bell H, Wilson J . Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours. Clin Otolaryngol Allied Sci. 1999; 24(1):52-4. DOI: 10.1046/j.1365-2273.1999.00211.x. View

ENEROTH C, Blanck C, JAKOBSSON P . Carcinoma in pleomorphic adenoma of the parotid gland. Acta Otolaryngol. 1968; 66(6):477-92. DOI: 10.3109/00016486809126313. View

Hellquist H, Karlsson M, Nilsson C . Salivary duct carcinoma--a highly aggressive salivary gland tumour with overexpression of c-erbB-2. J Pathol. 1994; 172(1):35-44. DOI: 10.1002/path.1711720108. View

Yamamoto Y, Kishimoto Y, Wistuba I, Virmani A, Vuitch F, Gazdar A . DNA analysis at p53 locus in carcinomas arising from pleomorphic adenomas of salivary glands: comparison of molecular study and p53 immunostaining. Pathol Int. 1998; 48(4):265-72. DOI: 10.1111/j.1440-1827.1998.tb03904.x. View

Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y . Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope. 1992; 102(8):923-7. DOI: 10.1288/00005537-199208000-00013. View

Slamon D, Godolphin W, Jones L, Holt J, Wong S, Keith D . Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989; 244(4905):707-12. DOI: 10.1126/science.2470152. View

10.

Onitsuka T . Sex hormones in papillary carcinoma of thyroid gland and pleomorphic adenoma of parotid gland. Acta Otolaryngol. 1994; 114(2):218-22. DOI: 10.3109/00016489409126046. View

11.

Shintani S, Funayama T, Yoshihama Y, Alcalde R, Ootsuki K, Terakado N . Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study. Anticancer Res. 1995; 15(6B):2623-6. View

12.

Li X, Tsuji T, Wen S, Mimura Y, Sasaki K, Shinozaki F . Detection of numeric abnormalities of chromosome 17 and p53 deletions by fluorescence in situ hybridization in pleomorphic adenomas and carcinomas in pleomorphic adenoma. Correlation with p53 expression. Cancer. 1997; 79(12):2314-9. DOI: 10.1002/(sici)1097-0142(19970615)79:12<2314::aid-cncr4>3.0.co;2-l. View

13.

SPIRO R, Huvos A, Strong E . Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases. Cancer. 1977; 39(2):388-96. DOI: 10.1002/1097-0142(197702)39:2<388::aid-cncr2820390204>3.0.co;2-d. View

14.

Allison R, Best T . p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry. J Oral Pathol Med. 1998; 27(9):434-40. DOI: 10.1111/j.1600-0714.1998.tb01981.x. View

15.

Lewis J, McKinney B, Weiland L, Ferreiro J, Olsen K . Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer. 1996; 77(2):223-30. DOI: 10.1002/(SICI)1097-0142(19960115)77:2<223::AID-CNCR1>3.0.CO;2-N. View

16.

Livolsi V, Perzin K . Malignant mixed tumors arising in salivary glands. I. Carcinomas arising in benign mixed tumors: a clinicopathologic study. Cancer. 1977; 39(5):2209-30. DOI: 10.1002/1097-0142(197705)39:5<2209::aid-cncr2820390540>3.0.co;2-8. View

17.

Shick P, Riordan G, Foss R . Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995; 80(4):440-4. DOI: 10.1016/s1079-2104(05)80338-5. View

18.

Kapadia S, Barnes L . Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma. Mod Pathol. 1998; 11(11):1033-8. View

19.

Olsen K, Lewis J . Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck. 2001; 23(9):705-12. DOI: 10.1002/hed.1100. View

20.

Ohtake S, Cheng J, Ida H, Suzuki M, Ohshiro K, Zhang W . Precancerous foci in pleomorphic adenoma of the salivary gland: recognition of focal carcinoma and atypical tumor cells by P53 immunohistochemistry. J Oral Pathol Med. 2002; 31(10):590-7. DOI: 10.1034/j.1600-0714.2002.00040.x. View